Alkermes (ALKS) Cash & Current Investments (2010 - 2026)
Alkermes (ALKS) reported Cash & Current Investments of $511.9 million for Q1 2026, down 42.1% year-over-year from $884.0 million in Q1 2025, and down 54.29% quarter-over-quarter from $1.1 billion in Q4 2025.
Alkermes (ALKS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Cash & Current Investments data on file, last reported at $511.9 million in Q1 2026.
- Cash & Current Investments for Q1 2026 came in at $511.9 million, down 42.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $511.9 million (down 42.1% YoY), and the FY2025 annual result was $1.1 billion, up 48.97% from the prior year.
- Cash & Current Investments slipped to $511.9 million in Q1 2026 per ALKS's latest filing, from $1.1 billion in the prior quarter.
- Over five years, Cash & Current Investments peaked at $1.1 billion in Q4 2025 and troughed at $511.9 million in Q1 2026.
- A 5-year average of $783.2 million and a median of $773.5 million in 2023 frame the typical range for Cash & Current Investments.
- The sharpest annual moves came in 2023 and 2026: Cash & Current Investments soared 53.25% in 2023, then tumbled 42.1% in 2026.
- A 5-year view of Cash & Current Investments shows it stood at $608.5 million in 2022, then gained by 27.12% to $773.5 million in 2023, then decreased by 2.82% to $751.7 million in 2024, then jumped by 48.97% to $1.1 billion in 2025, then tumbled by 54.29% to $511.9 million in 2026.
- Business Quant data shows ALKS's Cash & Current Investments at $511.9 million in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.74 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.94 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 2.15 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 77.77 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.32 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 428.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 511.86 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 750.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 498.58 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn | 222.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 511.86 Mn |
| Dec 31, 2025 | 1.12 Bn |
| Sep 30, 2025 | 1.11 Bn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 884.02 Mn |
| Dec 31, 2024 | 751.67 Mn |
| Sep 30, 2024 | 908.86 Mn |
| Jun 30, 2024 | 876.12 Mn |
| Mar 31, 2024 | 745.05 Mn |
| Dec 31, 2023 | 773.49 Mn |
| Sep 30, 2023 | 889.15 Mn |
| Jun 30, 2023 | 829.05 Mn |
| Mar 31, 2023 | 600.46 Mn |
| Dec 31, 2022 | 608.47 Mn |
| Sep 30, 2022 | 580.18 Mn |
| Jun 30, 2022 | 580.97 Mn |
| Mar 31, 2022 | 528.87 Mn |
| Dec 31, 2021 | 536.31 Mn |
| Sep 30, 2021 | 560.30 Mn |
| Jun 30, 2021 | 538.35 Mn |